# Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

> **NCT07457060** · PHASE4 · RECRUITING · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 480 (estimated)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** 2wIPV+1sIPV
- **BIOLOGICAL:** 1wIPV+2sIPV
- **BIOLOGICAL:** 3wIPV
- **BIOLOGICAL:** 3sIPV

## Key facts

- **NCT ID:** NCT07457060
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-27
- **Primary completion:** 2026-09-08
- **Final completion:** 2026-10-19
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457060, "Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07457060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*